Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Chiloiro

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Frontiers in Endocrinology|May 19, 2023
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumorsAntonio Bianchi, Sabrina Chiloiro, Antonella Giampietro, et al.
Neuroendocrinology|January 31, 2015
Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosisSabrina Chiloiro, Francesco Doglietto, Barbara Trapasso, et al.
Cancers|July 27, 2024
Topography and Radiological Variables as Ancillary Parameters for Evaluating Tissue Adherence, Hypothalamic-Pituitary Dysfunction, and Recurrence in Craniopharyngioma: An Integrated Multidisciplinary OverviewRosalinda Calandrelli, Gabriella D'Apolito, Matia Martucci, et al.
Endocrine|August 20, 2022
Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegalySabrina Chiloiro, Denise Costa, Rosa Lauretta, et al.
Frontiers in Endocrinology|September 16, 2024
GH receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: preliminary results of a pilot studySabrina Chiloiro, Flavia Costanza, Antonella Giampietro, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 20, 2025
Acromegaly and Morris Syndrome: Description of a Clinical CaseSimone Antonio De Sanctis, Sabrina Chiloiro, Antonella Giampietro, et al.
The Journal of Clinical Endocrinology and Metabolism|August 22, 2023
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in AcromegalySabrina Chiloiro, Stefano Frara, Irene Gagliardi, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 27, 2013
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomesAntonio Bianchi, Ferdinando Valentini, Raffaella Iuorio, et al.
Drugs in Context|May 31, 2024
Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiencesSabrina Chiloiro, Marialuisa Appetecchia, Antonio Bianchi, et al.
Journal of Personalized Medicine|March 29, 2023
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?Sabrina Chiloiro, Antonella Giampietro, Antonio Bianchi, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Frontiers in Endocrinology|May 19, 2023
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumorsAntonio Bianchi, Sabrina Chiloiro, Antonella Giampietro, et al.
Neuroendocrinology|January 31, 2015
Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosisSabrina Chiloiro, Francesco Doglietto, Barbara Trapasso, et al.
Cancers|July 27, 2024
Topography and Radiological Variables as Ancillary Parameters for Evaluating Tissue Adherence, Hypothalamic-Pituitary Dysfunction, and Recurrence in Craniopharyngioma: An Integrated Multidisciplinary OverviewRosalinda Calandrelli, Gabriella D'Apolito, Matia Martucci, et al.
Endocrine|August 20, 2022
Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegalySabrina Chiloiro, Denise Costa, Rosa Lauretta, et al.
Frontiers in Endocrinology|September 16, 2024
GH receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: preliminary results of a pilot studySabrina Chiloiro, Flavia Costanza, Antonella Giampietro, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 20, 2025
Acromegaly and Morris Syndrome: Description of a Clinical CaseSimone Antonio De Sanctis, Sabrina Chiloiro, Antonella Giampietro, et al.
The Journal of Clinical Endocrinology and Metabolism|August 22, 2023
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in AcromegalySabrina Chiloiro, Stefano Frara, Irene Gagliardi, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 27, 2013
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomesAntonio Bianchi, Ferdinando Valentini, Raffaella Iuorio, et al.
Drugs in Context|May 31, 2024
Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiencesSabrina Chiloiro, Marialuisa Appetecchia, Antonio Bianchi, et al.
Journal of Personalized Medicine|March 29, 2023
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?Sabrina Chiloiro, Antonella Giampietro, Antonio Bianchi, et al.
Pageof 12